3 Researchers Named 2021 Fellows of American Association for the Advancement of Science

Three UC San Francisco researchers have been selected as 2021 fellows of the American Association for the Advancement of Science (AAAS), the world's largest multidisciplinary scientific society and a leading publisher of cutting-edge research through its Science family of journals. They are among

UCSF Researchers Receive 2021 ASPIRE Awards for High-Risk, High-Reward Projects

Three scientific research projects led by UCSF investigators have been selected to receive 2021 ASPIRE Awards by the Mark Foundation for Cancer Research. The Mark Foundation's ASPIRE (Accelerating Scientific Platforms and Innovative Research) program enables innovative approaches to solving

Addressing High Lung Cancer Rates Among Female Asian Non-Smokers

While smoking is the top risk factor for lung cancer, Asian women in the United States who have never smoked are currently twice as likely to develop the disease than female non-smokers of other ethnicities. The FANS (Female Asian Never Smokers) Study aims to collect data from Asian American women

Human Proteins Behind COVID-19 Infection Revealed by Innovative CRISPR Technology

In the quest for new treatments for COVID-19, a team led by researchers at UC San Francisco has identified a new potential drug target that may block infection by SARS-CoV-2. The protein, called BRD2, regulates the ACE2 receptor, which the novel coronavirus relies on to gain entry to its host’s

Sorting Cancers by ‘Immune Archetypes’ May Offer New Approach For Precision Immunotherapies

Using data from over 300 patient tumors, UC San Francisco researchers have described 12 classes of “immune archetypes” to classify cancer tumors. Their findings, published this week in CELL, reveal that cancers from different parts of the body are immunologically similar to one another. These

Alpha Coronavirus Variant Evolved to Evade Immune System

The Alpha variant of SARS-CoV-2 – the first variant of concern – evolved mutations that allowed it to more efficiently suppress the immune system’s early response to infection, according to a new study led by scientists at the UC San Francisco’s Quantitative Biosciences Institute (QBI) and

Surgical Procedure Helps Cancer Patients Face Themselves Again

For patients undergoing facial reconstruction following disfiguring cancer operations, a new technique pioneered by surgeons at UC San Francisco may enable them to look more like their former selves. Typically, the use of skin from other parts of the body for facial skin reconstruction, has led to